Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

802 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17.
Yamane H, Ochi N, Nagasaki Y, Yamagishi T, Honda Y, Nakagawa N, Takeyama M, Nakanishi H, Takigawa N. Yamane H, et al. Among authors: nakagawa n. Ther Clin Risk Manag. 2018 Aug 21;14:1457-1465. doi: 10.2147/TCRM.S169824. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 30174428 Free PMC article.
Lung cancer metastasis to the pancreas mimicking autoimmune pancreatitis.
Ichiyama N, Yamane H, Ochi N, Nakagawa N, Nagasaki Y, Kawahara T, Taoka M, Mimura A, Nakanishi H, Takigawa N. Ichiyama N, et al. Among authors: nakagawa n. Thorac Cancer. 2021 May;12(9):1467-1468. doi: 10.1111/1759-7714.13951. Epub 2021 Apr 3. Thorac Cancer. 2021. PMID: 33811749 Free PMC article.
IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy.
Taoka M, Ochi N, Mimura A, Ichiyama N, Nagasaki Y, Nakagawa N, Nakanishi H, Yamane H, Oshiro Y, Monobe Y, Takigawa N. Taoka M, et al. Among authors: nakagawa n. Ther Clin Risk Manag. 2021 Jun 3;17:571-575. doi: 10.2147/TCRM.S308771. eCollection 2021. Ther Clin Risk Manag. 2021. PMID: 34113114 Free PMC article.
Targeting ROR1 in combination with osimertinib in EGFR mutant lung cancer cells.
Nakagawa N, Miyake N, Ochi N, Yamane H, Takeyama M, Nagasaki Y, Ikeda T, Yokota E, Fukazawa T, Nakanishi H, Harada D, Kiura K, Takigawa N. Nakagawa N, et al. Exp Cell Res. 2021 Dec 15;409(2):112940. doi: 10.1016/j.yexcr.2021.112940. Epub 2021 Nov 19. Exp Cell Res. 2021. PMID: 34808132
Descending necrotizing mediastinitis in a healthy young adult.
Ochi N, Wakabayashi T, Urakami A, Yamatsuji T, Ikemoto N, Nagasaki Y, Nakagawa N, Honda Y, Nakanishi H, Yamane H, Monobe Y, Akisada T, Katayama H, Naomoto Y, Takigawa N. Ochi N, et al. Among authors: nakagawa n. Ther Clin Risk Manag. 2018 Oct 17;14:2013-2017. doi: 10.2147/TCRM.S176520. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 30425498 Free PMC article.
802 results